TY - JOUR T1 - Modeling-based UV-C decontamination of N95 masks optimized to avoid undertreatment JF - medRxiv DO - 10.1101/2020.10.30.20223354 SP - 2020.10.30.20223354 AU - Adam P. Sears AU - Jacques Ohayon AU - Anton D. Shutov AU - Roderic I. Pettigrew Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/11/04/2020.10.30.20223354.abstract N2 - As the Coronavirus 2019 pandemic creates worldwide shortages of personal protective equipment, hospitals have increasingly turned to sterilization and re-use protocols, often without significant data supporting the specific methodologies. When using UV-C irradiation, previously shown to be effective for decontaminating hard surfaces, modeling shows the importance of accounting for the porosity and non-uniform curvature of the N95 masks in decontamination procedures. Data shows a standard incident dose of 1 J/cm2 delivered to both front and back surfaces is more than 500x higher than the known kill dose. However, modeling indicates this would undertreat 40% of the mask material due to the curvature, path-length attenuation and scatter. Multidirectional UV-C irradiation employing dose calibrated exposures can adjust for this loss and best decontaminate masks. Such protocols can be rapidly implemented in thousands of hospitals across the world equipped with UV-C irradiation lamps without the need for additional capital equipment purchases.Competing Interest StatementRP and APS have recently applied for a patent based on the model concept.Funding StatementNo external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB approval necessaryAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCode will be released upon journal publication https://github.com/PettigrewLab/N95Simulation ER -